← All organizations

AAIPharma

For profit

Also known as: AAI | AAI, 6101 Quadrangle Drive, Chapel Hill, NC 27514 | AAI Clinic | AAI Clinic (AAIPharma Inc.) | AAI Deutschland GmbH & Co. KG | AAIOncology | aaiPharma | aai Pharma | AAIPharma | AAIPharma Deutschland GmbH & Co. KG | AAIPharma Inc., AAI Clinic | AAIPHARMA LLC | AAI Scientific Cultural Services Ltd (AAISCS)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jan 1, 2017

Acquired by Alcami on Jan 1, 2013

Timeline

1970s

Sep 9, 1971
acetylsalicylic acid— NDA Secondary Org
Jun 1, 1979
AAIPharma— Founded

1990s

Jun 7, 1999
azathioprine— Marketing Organization

2010s

Jan 1, 2013
Alcami— Acquired By

Drugs by trial phase (21 distinct, 28 trials)

Phase 3 (1 own, 0 via acquisition)

ibuprofen

Phase 2 (3 own, 0 via acquisition)

Phase 1 (15 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (5)

Recent trials (30)

NCT02991781CollaboratorN/AJan 1, 2017
NCT00773630Overall official - principal investigatorPhase 1Dec 1, 2008
NCT00780182Overall official - principal investigatorPhase 1Oct 1, 2008
NCT01034735Overall official - principal investigatorPhase 1Jul 1, 2008
NCT00709215CollaboratorPhase 1/Phase 2Jun 1, 2008
NCT00707057CollaboratorPhase 3Jun 1, 2008
NCT00559052CollaboratorPhase 2Mar 1, 2008
NCT01933971CollaboratorPhase 1Jun 1, 2007
NCT00864604Overall official - principal investigatorPhase 1Apr 1, 2007
NCT00864968Overall official - principal investigatorPhase 1Feb 1, 2007
NCT00551512Study directorPhase 1Nov 1, 2006
NCT00863902Overall official - principal investigatorPhase 1Aug 1, 2006
NCT00864279Overall official - principal investigatorPhase 1Aug 1, 2006
NCT01222923Overall official - principal investigatorN/AOct 1, 2004
NCT01131975Overall official - principal investigatorPhase 1Jan 1, 2003

Details

Founded: Wilmington, NC, US Jun 1, 1979
Last known activity: Jan 1, 2017